The Dark Arts of Pharmaceutical Mergers and Acquisitions Recent rumors of AstraZeneca's potential takeover bid for Bristol Myers Squibb have left many in the pharmaceutical industry perplexed.
While talks were reportedly abandoned, the mystery surrounding them raises questions about Sir Pascal Soriot's decision making process.
The proposed deal would have created a behemoth with a market value exceeding $400 billion, making it one of the largest pharmaceutical companies worldwide.